The SUMOylation of PML at the SUMO site K160 is essential for APL initiation and maintenance, and the inactivation of K160 impairs the differentiation blockade and immortalization of APL cells [178] (Figure 2A). The gene discussed is PML; the disease is acute promyelocytic leukemia.